Hepatitis C virus infection: quality of life and side effects of treatment (Q33809625)

29 July 2017

title

Hepatitis C virus infection: quality of life and side effects of treatment (English)

1 reference

29 July 2017

1 reference

1 reference

1 reference

Foster GR

1 reference

29 July 2017

language of work or name

1 reference

1 January 1999

1 reference

29 July 2017

published in

Journal of Hepatology

1 reference

29 July 2017

volume

31 Suppl 1

1 reference

29 July 2017

page(s)

250-254

1 reference

Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980411-5

7 January 2021

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980411-5

7 January 2021

Speech and survival: tradeoffs between quality and quantity of life in laryngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980411-5

7 January 2021

The Sickness Impact Profile: Development and Final Revision of a Health Status Measure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980411-5

7 January 2021

Effect of interferon-alpha treatment of chronic hepatitis C on health-related quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980411-5

7 January 2021

Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980411-5

7 January 2021

Measuring functional status of stroke patients with the Sickness Impact Profile

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980411-5

7 January 2021

Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980411-5

7 January 2021

Health assessment for chronic HCV infection: results of quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980411-5

7 January 2021

10.1016/S0168-8278(99)80411-5

Identifiers

DOI

1 reference

29 July 2017

1 reference